Skip to Main Content
Wyss Institute
Menu
Search Site
Who We Are
About
How We Work
How We Collaborate
Team
Careers
Contact
Our Work
Technologies
Impact Report
Business Insider
Publications
Collaborations
Brain Targeting Program
Collaborative Fund Alliance
Diagnostics Accelerator
i3 Center
Northpond Labs Alliance
Newsroom
News
Press Resources
Multimedia
Events
Give
Search
News search results
5 Results for ''
Translation News
CRISPR’s Impact, Today
October 21, 2024
Translation News
Attivare licenses Wyss Institute’s immune-modulating biomaterial technology to advance immunotherapies
October 2, 2024
Translation News
In a first, genetically edited pig kidney is transplanted into human
March 22, 2024
Press Release
Using the body’s own cells to treat traumatic brain injury
January 3, 2024
Translation News
Wyss Institute’s infant health-promoting technology licensed to Prapela
August 22, 2018
Close search results
close menu
Who We Are
About
How We Work
How We Collaborate
Team
Careers
Contact
Our Work
Technologies
Impact Report
Business Insider
Publications
Collaborations
Brain Targeting Program
Collaborative Fund Alliance
Diagnostics Accelerator
i3 Center
Northpond Labs Alliance
Newsroom
News
Press Resources
Multimedia
Events
Give
Close menu
